Novel Insulin Delivery Systems Pump New Life Into Diabetes Device Market

The market for insulin delivery devices is positioned to change significantly with several manufacturers gearing their products toward type 2 diabetics, who make up 90% to 95% of the diabetes patient pool in the US. These new, “pump-like” devices could offer the type 2 diabetes population better control in managing glucose levels, a solution the medical community has been seeking for a while.

The way diabetic patients receive insulin and manage their disease could go through some major changes in the next few years, and that is turning the field into a very active marketplace that medical professionals as well as investors are watching closely. The major shift starts with insulin injections, which will remain a key component of managing blood sugar levels, but new delivery systems are offering a more appealing alternative to the pain, inconvenience, and stigma of using syringes, and manufacturers are pursuing the large type 2 (T2) diabetic population for these new systems.

The benchmark of progress in diabetes treatments is usually measured at the American Diabetes Association (ADA) annual industry conference, and...

More from United States

More from North America